Short Interest In Progenics Pharmaceuticals Increases 14.8%
August 12, 2014 at 14:54 PM EDT
The most recent short interest data has been released by the NASDAQ for the 07/31/2014 settlement date, which shows a 1,125,393 share increase in total short interest for Progenics Pharmaceuticals, Inc. (PGNX), to 8,716,444, an increase of 14.83% since 07/15/2014..